The chemokine-binding protein M3 as a tool to understand the chemokine network in vivo.

[1]  S. Lira,et al.  Islet Expression of M3 Uncovers a Key Role for Chemokines in the Development and Recruitment of Diabetogenic Cells in NOD Mice , 2008, Diabetes.

[2]  D. Fremont,et al.  The Chemokine Binding Protein M3 Prevents Diabetes Induced by Multiple Low Doses of Streptozotocin1 , 2007, The Journal of Immunology.

[3]  B. Rollins,et al.  The Chemokine Decoy Receptor M3 Blocks CC Chemokine Ligand 2 and CXC Chemokine Ligand 13 Function In Vivo1 , 2006, The Journal of Immunology.

[4]  H. Drexhage,et al.  Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre‐diabetic islets in NOD mice , 2005, European journal of immunology.

[5]  T. Saruta,et al.  CXC Chemokine Ligand 10 Neutralization Suppresses the Occurrence of Diabetes in Nonobese Diabetic Mice through Enhanced β Cell Proliferation without Affecting Insulitis , 2004, The Journal of Immunology.

[6]  P. Frenette,et al.  A Novel Model for Lymphocytic Infiltration of the Thyroid Gland Generated by Transgenic Expression of the CC Chemokine CCL211 , 2004, The Journal of Immunology.

[7]  A. Alcamí,et al.  Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3. , 2004, The American journal of pathology.

[8]  A. Alcamí.  Structural basis of the herpesvirus M3-chemokine interaction. , 2003, Trends in microbiology.

[9]  C. Mathieu,et al.  IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice , 2003, Diabetologia.

[10]  Timothy N. C. Wells,et al.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Alcamí,et al.  Disruption of CCL21-Induced Chemotaxis In Vitro and In Vivo by M3, a Chemokine-Binding Protein Encoded by Murine Gammaherpesvirus 68 , 2003, Journal of Virology.

[12]  M. Atkinson,et al.  Fatal attraction: chemokines and type 1 diabetes. , 2002, Journal of Clinical Investigation.

[13]  Tracy M. Handel,et al.  Structural Basis of Chemokine Sequestration by a Herpesvirus Decoy Receptor , 2002, Cell.

[14]  J. Cyster,et al.  Differing Activities of Homeostatic Chemokines CCL19, CCL21, and CXCL12 in Lymphocyte and Dendritic Cell Recruitment and Lymphoid Neogenesis1 , 2002, The Journal of Immunology.

[15]  S. Lira,et al.  Ectopic Expression of the Murine Chemokines CCL21a and CCL21b Induces the Formation of Lymph Node-Like Structures in Pancreas, But Not Skin, of Transgenic Mice , 2002, The Journal of Immunology.

[16]  K. Jensen,et al.  Disruption of Neutrophil Migration in a Conditional Transgenic Model: Evidence for CXCR2 Desensitization In Vivo , 2001, The Journal of Immunology.

[17]  R. Alon,et al.  Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines , 2001, Nature Immunology.

[18]  D. Fremont,et al.  Identification of a Gammaherpesvirus Selective Chemokine Binding Protein That Inhibits Chemokine Action , 2000, Journal of Virology.

[19]  D. Hanahan,et al.  BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. , 2000, Immunity.

[20]  A. Alcamí,et al.  A Broad Spectrum Secreted Chemokine Binding Protein Encoded by a Herpesvirus , 2000, The Journal of experimental medicine.

[21]  Tong-Yuan Yang,et al.  Transgenic Expression of the Chemokine Receptor Encoded by Human Herpesvirus 8 Induces an Angioproliferative Disease Resembling Kaposi's Sarcoma , 2000, The Journal of experimental medicine.

[22]  B. Tyrberg,et al.  Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. , 1999, Diabetes.

[23]  D. Altmann,et al.  Streptozotocin‐induced diabetes in mice lacking αβ T cells , 1997 .

[24]  Tomoko Nakanishi,et al.  ‘Green mice’ as a source of ubiquitous green cells , 1997, FEBS letters.

[25]  C. Janeway,et al.  Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells , 1996, The Journal of experimental medicine.

[26]  R. Bravo,et al.  Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. , 1995, Journal of immunology.

[27]  N. Kwon,et al.  Nitric oxide generation from streptozotocin 1 , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  G. Korbutt,et al.  Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. , 1992, The Journal of clinical investigation.

[29]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Foulis.  The pathogenesis of beta cell destruction in type I (insulin‐dependent) diabetes mellitus , 1987 .

[31]  A. Monaco,et al.  An improved method for isolation of mouse pancreatic islets. , 1985, Transplantation.

[32]  A. Rossini,et al.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. , 1976, Science.

[33]  David Bouchez,et al.  Manipulating the Mouse Embryo , 2007 .

[34]  Antonio Alcami,et al.  Viral mimicry of cytokines, chemokines and their receptors , 2003, Nature Reviews Immunology.

[35]  L. Adorini,et al.  Understanding autoimmune diabetes: insights from mouse models. , 2002, Trends in molecular medicine.

[36]  H. Jun,et al.  Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. , 1998, Autoimmunity.

[37]  A. Rot.  Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. , 1992, Immunology today.

[38]  H. Kolb,et al.  A role for macrophages in the pathogenesis of type 1 diabetes. , 1989, Autoimmunity.